NeuraLight is building an AI-driven platform to accelerate and improve drug development, monitoring, and care for patients with neurological disorders by using information captured with a standard smartphone or webcam. The companys platform automatically extracts micro-oculometrics, providing objective and sensitive digital markers for neurological disorders. The solution is designed to serve as a robust proxy for currently used endpoints and to ultimately define a new measurement standard, paving the path for precision medicine in neurology. NeuraLight is focused on transforming the lives of the billions of people impacted by neurological disorders by digitizing patient evaluation and care. Its vision is a world where neurological disorders can be prevented, diagnosed, and treated effectively so that people can live longer, healthier lives.